Intrinsic susceptibility contrast (R2*) in the evaluation of tumour oxygenation at baseline and in response to neoadjuvant chemotherapy in breast cancer

نویسندگان

  • S. P. Li
  • N. J. Taylor
  • J. J. Stirling
  • M-L. W. Ah-See
  • M. J. Beresford
  • D. J. Collins
  • J. A. d'Arcy
  • A. Makris
  • A. R. Padhani
چکیده

Introduction: The ability to image tumour hypoxia and evaluate oxygenation changes in response to treatment using R2* is a powerful yet underexplored tool in breast cancer in humans [1]. This study evaluates the relationship between baseline histology and dynamic contrast enhanced (DCE) and dynamic susceptibility enhanced (DSC) MRI parameters with R2* in breast cancer. The role of R2* as an imaging biomarker of response to neoadjuvant chemotherapy (NAC) is also explored. Methods: 37 patients with solid, well defined, primary invasive ductal breast adenocarcinomas were imaged with a spoiled multi-gradient echo T2*-weighted MRI sequence (TE 5-75ms, TR100s, flip angle (α) 40 ̊, 8mm slice thickness, FOV 260mm, 256 matrix). T1-weighted DCE-MRI sequences (TE 4.7ms, TR 11ms, α 35 ̊, 256 matrix) and DSC-MRI sequences (TE 20ms, TR 30ms, α 40 ̊, 128 matrix) were also performed using 0.1mmol/kg and 0.2 mmol/kg body weight of Gd-DTPA respectively. R2* values were calculated using a least-squares fitting routine on ln[signal] plotted against TE. DCE-MRI images were analysed with Tofts’ pharmacokinetic model [2] and a modified Fritz-Hansen assumed arterial input function [3] using specialist MRIW software (Institute of Cancer Research, London) [4]. DSC parameters were calculated from a fitted Γ−variate function using MRIW [4]. Whole tumour ROI parametric values were acquired: R2*, K, ve, kep, IAUGC60, rBV, rBF and the MTT of the fitted curve. Relationships between baseline R2* and tumour characteristics (size, grade, ER/PR/HER2 status) and DCE and DSC-MRI parameters were explored using Spearman’s rank correlation for continuous variables and the Mann-Whitney U test for discrete variables. Baseline R2* and changes in R2* with treatment were also correlated with final pathological response using paired t-testing. R2* was compared with DCE and DSC kinetic parameters as a predictor of response using ROC (receiver operating characteristic curve) analyses.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Predictive ability of 18F-fluorodeoxyglucose positron emission tomography/computed tomography for pathological complete response and prognosis after neoadjuvant chemotherapy in triple-negative breast cancer patients

Objective The mortality of patients with locally advanced triple-negative breast cancer (TNBC) is high, and pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) is associated with improved prognosis. This retrospective study was designed and powered to investigate the ability of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) to predict pat...

متن کامل

Association of tumor infiltration lymphocytes and complete pathological response in breast cancer patients under neoadjuvant chemotherapy

Background: The breast cancer is the most common type of cancer in Iran. Hence determination of the optimal treatment and the contributing factors are important. The main aim in current study was to determine the association between tumor infiltration of lymphocytes (TIL) and complete pathological response in breast cancer patients after neoadjuvant chemotherapy. Methods and materials: In this...

متن کامل

Prognostic Significance of Reduction in Ki67 Index After Neoadjuvant Chemotherapy in Patients With Breast Cancer in Kerman Between 2009 And 2014

Background and objective:Breast cancer is the most common malignancy among women. The Neoadjuvant chemotherapy is the treatment of choice for non-operable tumors. The Ki67 is a proliferation marker that can be used to predict the therapeutic response to chemotherapy and the patients' prognosis. Methods: This retrospective study was carri...

متن کامل

Dissection axillary lymph node count in patient with breast cancer followed by neoadjuvant therapy

Introduction: Breast cancer is the most common cancer and the second cause of death in women. It is essential to have the highest level of confidence in axillary staging assessment. Many surgeons and pathologists believe that fewer lymph nodes are present in axillary dissection specimens of women treated by neoadjuvant chemotherapy. Consequently, the purpose of this study was to compare the lym...

متن کامل

Response to neoadjuvant chemotherapy in locally advanced gastric and gastroesophageal cancer: Phase II clinical trial

Background: Gastric cancer is an important health problem across the world. Chemotherapy in combination with local treatment is standard treatment for locally advanced gastroesophageal cancers. The purpose of this investigation was evaluation of response and tolerability to neoadjuvant EOX regimen in locoregionally advanced gastric cancer. Materials and Methods: patients with locoregionally adv...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2009